TOA EIYO aims to be a specialized pharmaceutical company that is truly indispensable to the medical front lines via our research and development on new medicines and value-added generic drugs in the cardiovascular and related fields.
We recognize that licensing and alliances are an indispensable and a valuable business strategy for establishing our solid pipeline of innovative treatments for patients.
We are proactively seeking new partnerships with many more pharmaceutical, biotechnology companies, and other partners, both in and outside of Japan.
Please contact us if you have an interest in collaborating with us.